Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Hikma’s U.S. unit raises medicine prices

Hikma Pharmaceuticals Plc’s U.S. subsidiary raised the price of a common diarrhea drug by more than 400 percent and is charging more for five other medicines.

Read More »

NIH scientist to head up Pfizer unit

Thomas Wynn, after serving 26 years as a senior investigator at the National Institutes of Health (NIH), left to lead Pfizer’s inflammation and immunology unit.

Read More »

Bayer, J&J win another Xarelto U.S. trial

A federal jury cleared Bayer and J&J of liability in the third case to go to trial out of thousands of lawsuits claiming their blood thinner Xarelto led to severe internal bleeding.

Read More »

The Greater Than One Group Appoints Jim Plattner Global Chief Financial Officer

The Greater Than One Group (GTO) announced that James P. Plattner joined the firm as Global Chief Financial Officer.

Read More »

Insys agrees to resolve Illinois opioid lawsuit

Insys Therapeutics Inc. agreed to pay $4.45 million to resolve a lawsuit by Illinois’ attorney general claiming it deceptively marketed an addictive fentanyl-based cancer pain drug for off-label uses.

Read More »

Philippines reports second outbreak of bird flu

The Philippines found a second outbreak of bird flu in another province in the main Luzon island, Agriculture Secretary Emmanuel Pinol said, a week after reporting the country’s first case of the poultry disease.

Read More »

FDA expands use of ovarian cancer drug

The FDA expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co. Inc., and approved a new two-tablet regimen for the drug.

Read More »

FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection

As an additional measure in the fight against Zika virus, the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to detect recent Zika virus infection.

Read More »

FDA approves rare blood cancer drug

The U.S. Food and Drug Administration approved Pfizer Inc.’s rare blood cancer drug Besponsa with a boxed warning.

Read More »

Deficiencies in early brain activity linked to delinquent behavior in teens

Lower levels of brain activity during childhood may lead to decreased self-control and, eventually, delinquent behavior in adolescence, according to a new study published by a team of researchers from FIU and the University of Michigan.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom